SV

Street Verdict

Analyst Scorecard

A record of what ETMarkets Analysis said publicly, with the source. Not advice.

“Medium-term traders are advised to buy Torrent Pharma, targeting ₹4,400 in the next 3-4 months. This call follows the stock's breakout from a Cup & Handle formation on weekly charts, reaching a fresh record high and indicating an anticipated uptrend continuation.”

ETMarkets Analysis’s track record (trackable calls only): 193 graded calls · 95% CI 23–35%

Torrent Pharmaceuticals LtdBullishCalled 17 Nov 2025Graded 25 Feb 2026
Verdict:HIT

How this call is judged

A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate.

No entry price is stated, so the call starts at the first close after it was published.

Target ₹4,400, as stated.

Window: 120 days, the time frame the call states ("3-4 months").

The target ₹4,400 was reached on a close. Hit.

The grader’s working: R4 TARGET_CALL: entered ₹3790.8 on 2025-11-18 (next trading session's close); target ₹4400 reached at close ₹4418.9 on 2026-02-25. Window 120 days — rule H1: the quote states "3-4 months".

How it played out

How this is worked out
Time to target
The target was reached on a close 68 trading sessions (99 calendar days) after the entry.
Worst close against it
The closing price went as far as 2.75% against the call before the target was reached, measured from the entry price. Closing prices only; an intraday dip is never counted.

From the entry the grade used, on closing prices. This is a record of one past call and is not advice.

Tracking Torrent Pharmaceuticals Ltd since this call

1-year tracking window
Read the original articleSee ETMarkets Analysis’s full track record